Skip to main content
main-content

The independent medical news service

17-09-2019 | Oncology | News | Article

Notable number of patients taking immune checkpoint inhibitors hospitalized with irAEs

Patients receiving immune checkpoint inhibitor treatment have an increased risk for being hospitalized with immune-related adverse events, particularly if they are older or taking combination treatments, researchers report.

12-09-2019 | Oncology | News | Article

microRNA plus LDCT guides optimal lung cancer screening intensity

Combining low-dose computed tomography with a blood microRNA test can help establish the most appropriate screening frequency among heavy smokers at risk for lung cancer, study data show.

11-09-2019 | Oncology | News | Article

VATS in-hospital outcomes may better those of open lobectomy

Video-assisted thoracic surgery lobectomy is associated with less pain, fewer in-hospital complications, and shorter hospital stays compared with open lobectomy for early-stage lung cancer, data from the VIOLET study indicate.

08-09-2019 | Oncology | News | Article

Treatment hope for KRAS-mutated advanced NSCLC

AMG 510, a novel KRAS inhibitor, has promising efficacy and tolerability in previously treated patients with locally advanced or metastatic non-small-cell lung cancer carrying a KRAS G12C mutation, according to phase I trial findings.

02-09-2019 | Oncology | Main feed | Article

Elevated cardiovascular risk seen in survivors of most common cancers

Survivors of the 20 most common site-specific cancers, including lung and prostate, are at increased risk for cardiovascular disease in the years that follow diagnosis and treatment, show data published in The Lancet.

20-08-2019 | Oncology | News | Article

Study supports use of fosnetupitant in combination with palonosetron for CINV

A phase II trial shows that the intravenous prodrug fosnetupitant in combination with palonosetron reduces chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Image Credits